Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
i-jun.lau@ndorms.ox.ac.uk

I-Jun Lau

Senior Clinical Research Fellow in Translational Myeloma Research

Recent publications

MYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemia.

Lau I-J. et al, (2026), Blood

Monoclonal light chain glycosylation is associated with evolution of incidental MGUS

Larham J. et al, (2025), BLOOD, 146, 2185 - 2186

TRANSCRIPTION ELONGATION AND ABERRANT ENHANCER ACTIVATION IN LEUKEMIA

Milne T. et al, (2025), EXPERIMENTAL HEMATOLOGY, 151

The Utility of Mass Spectrometry in Defining Minimal Residual Disease in Treated Multiple Myeloma Patients

Campbell L. et al, (2024), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 24, S144 - S145

Sustained MYB activity is necessary for oncogenic transcription in KMT2A-rearranged acute lymphoblastic leukemia through enhancer-promoter interactions and epigenetic modifications at enhancers

Lau I-J. et al, (2023), Blood, 142, 40 - 41

More publications